Panacea Life Sciences Holdings, Inc. Cost of Revenue
Panacea Life Sciences Holdings, Inc. (PLSH) reported Cost of Revenue of $2.72 million for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-04-23.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2021-04-23
- Panacea Life Sciences Holdings, Inc. cost of goods and services sold for fiscal 2020 was $2.72M, a 32.92% increase from fiscal 2019.
- Panacea Life Sciences Holdings, Inc. cost of goods and services sold for fiscal 2019 was $2.05M.
- Panacea Life Sciences Holdings, Inc. cost of goods and services sold for fiscal 2018 was $0.00.
| Period end | Cost of Goods and Services Sold 12 month |
|---|---|
| 2020-12-31 | $2.72M 10-K/A · filed 2021-04-23 |
| 2019-12-31 | $2.05M 10-K/A · filed 2021-04-23 |
| 2018-12-31 | $0.00 10-K · filed 2020-05-22 |